 |
trientine tetrahydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment of Wilson’s disease |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-10 00:00:00 |
| Sponsor | GMP-Orphan SAS;Voisin Consulting, Inc., 222 Third Street, Suite 3121;Cambridge, Massachusetts, 02142 |
